SCAの最新情報をお伝えします。
- SCA event2022.6.27
- (日本語) 幹細胞評価基盤技術研究組合の解散について
- Project event2022.4.19
- (日本語) AMEDプロジェクト「再生医療技術を応用した創薬基盤技術の開発」（AMED-MPS事業）の終了
- Project event2022.3.9
- (日本語) 「ＡＭＥＤ−ＭＰＳ事業で製品化検討中のＭＰＳデバイスについて」更新
- Project event2022.2.8
- (日本語) 「ＡＭＥＤ−ＭＰＳ事業で製品化検討中のＭＰＳデバイスについて」更新
- SCA event2021.10.19
- (日本語) 再生医療JAPAN2021に組合展示ブースを出展
About of SCA
Stem Cell Evaluation Technology Research Association (SCETRA) is a not-for-profit research and development organization, headquartered in Tokyo, Japan;
The SCETRA specializes in supporting the development and practical application of advanced technologies using human stem cells by collaboration with union members.
Scope of Business
In this project, SCA performs development of each process of expansion culture, differentiation culture, isolation and purification, processing, preservation, quality control etc. of human stem cells, and constructs manufacturing systems by optimally combining each process.
